Mechanism of action of isoflavones;Mecanismo de acción de las isoflavonas

Ginecologia y Obstetricia Clinica

Volumn 6, Issue 3, 2005, Pages 159-165

  Navarro Moll, Ma Concepción ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Daidzein; Genistein; Isoflavones; Mechanisms of action; Phytoestrogens

Indexed keywords

DAIDZEIN; ESTROGEN RECEPTOR; GENISTEIN; ISOFLAVONE; PHENOL DERIVATIVE; PHYTOESTROGEN;

ANTIOXIDANT ACTIVITY; CEREAL; DERIVATIZATION; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; MENOPAUSE; PHYTOCHEMISTRY; PROPHYLAXIS; REVIEW; SOYBEAN; SYMPTOMATOLOGY;

EID: 28044463781     PISSN: 16953827     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC. Estrogen receptor β-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 2001;276:17808-14.
2. Beltrán E. Interés terapéutico de los fitoestrógenos en Ginecología: una revisión de las evidencias. Rev Fitoter 2003;4:23-40.
3. Chen XW, Garner SC, Anderson JJ. Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. Biochem Biophys Res Commun 2002;295:417-22.
4. Dubey RK, Gillespie DG, Imthurn B, Rosselli M, Jackson EK, Keller PJ. Phytoestrogens inhibit growth and MPA kinase activity in human aortic smooth muscle cells. Hypertensión 1999;33: 177-82.
5. Figtree GA, Griffiths H, Lu YQ, Webb CM, Mc Leod K, Collins P. Plant-derived estrogen relax coronary artery in vitro by a calcium antagonist mechanism. Am J Coll Cardiol 2000;35:1977-85.
6. Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angionesis. J Nutr 1995;125(3 Suppl): 790s-7s
7. Fritz KL, Seppanen CM, Kurzer MS, Csallany AS. The in vivo antioxidant activity of soybean isoflavones in human subjects. Nutr Res 2003;23:479-87.
8. Gao YH, Yamaguchi M. Suppressive effect of genistein on rat bone osteoclasts: involvement of protein kinase inhibition and protein tyrosine phosphatase activation. Int J Mol Med 2000;5:261-7.
9. Heim M, Frank O, Kampmann G, Sochoky N, Pennimpede T, Fuchs P, Hunziker W, Weber P, Martin I, Bendik I. The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinology 2004;145:848-59.
10. Hu JY, Aizawa T. Quantitative structure-activity relationships for estrogen receptor binding affinity of phenolic chemicals. Water Res 2003; 37:1213-22.
11. Kajiya H, Okabe K, Okamoto F, Tsuzuki T, Soeda H. Protein tyrosine kinase inhibitors increase cytosolic calcium and inhibit actin organization as resorbing activity in rat osteoclasts. J Cell Physiol 2000;183:83-90.
12. Kiriakidis S, Hogemeier O, Starcke S, Dombrowski F, Hahne JC, Pepper M, Jha HC, Wernert N. Novel tempeh (fermented soyabean) isoflavonas inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay. Br J Nutr 2005;93:317-23.
13. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-63.
14. Le Bail JC, Champavier Y, Chulia AJ, Habrioux G. Effects of phytoestrogens on aromatase, 3 beta and 17 beta-hydroxysteroid dehidrogenase activities and human breast cancer cells. Life Sci 2000;66:1281-91.
15. Lephart ED, Setchell KDR, Lund TD. Phytoestrogens: hormonal action and brain plasticity. Brain Res Bull 2005;65:193-8.
16. Nakashima S, Koike T, Nozawa Y. Genistein, a protein kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses. Mol Pharmacol 1990;39:745-80.
17. Navarro MC, Beltrán E. Fitoestrógenos: Posibilidades terapéuticas. Rev Fitoter 2001;1:165-80.
18. Pino AM, Valladares LE, Palma MA, Mancilla AM, Yánez M, Albala C. Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J Clin Endocrinol Metab 2000; 85:2797-800.
19. Setchell DR. Soy isoflavones. Benefits and risks form nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 2001;20:354s-62s.
20. Solanky KS, Bailey NJ, Beckwith-Hall BM, Bingham S, Davis A, Holmes E, Nicholson JK, Cassidy A. Biofluid 1H NMR-based metabonomic techniques in nutrition research: metabolic effects of dietary isoflavonas in humans. J Nut Biochem 2005;16:236-44.
21. Squadrito F, Altavilla D, Morabito N, Crisafulli A, D'Anna R, Corrado F, et al. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium-dependent vasodilation in postmenopausal women. Atherosclerosis 2002; 163:339-47.
22. Walker HA, Dean TS, Sanders TA, Jackson G, Ritter JM, Chowienczyk PJ. The phytoestrogen genisteína produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17beta-estradiol. Circulation 2001;16:258-62.
23. Yousef MI, Kamel KI, Esmail AM, Baghdadi HH. Antioxidant activities and lipid lowering effects of isoflavone in male rabbits. Food Chem Toxicol 2004;42:1497-503.
24. Zeng H, Chen Q, Zhao B. Genistein ameliorates β-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis. Free Radic Biol Med 2004; 36:180-8.